Schedule 13D ownership disclosure

Aurinia Pharmaceuticals Inc

Security class unavailable · CUSIP: 05156V102

Event date: 2020-10-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-113903
Form type
SC 13D/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Oct 09, 2020
Reporting period
Oct 07, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub